GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of Dacomitinib, a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutati

dc.contributor.author	Quindós Varela, María
dc.date.accessioned	2017-06-07T07:11:27Z
dc.date.available	2017-06-07T07:11:27Z
dc.date.issued	2015
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/20.500.11940/3625
dc.language.iso	eng
dc.title	GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of Dacomitinib, a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutati
dc.type	Artigo	es
dc.authorsophos	Sepulveda, J. M.
dc.authorsophos	Vaz, M. A.
dc.authorsophos	Gil, M.
dc.authorsophos	Reynes, G.
dc.authorsophos	Gallego, O.
dc.authorsophos	Bolos, M. V.
dc.authorsophos	Hernandez Lain, A.
dc.authorsophos	Sanchez-Gomez, P.
dc.authorsophos	Martinez, M.
dc.authorsophos	Vicente, E.
dc.authorsophos	Quindos, M.
dc.authorsophos	Luque, R.
dc.authorsophos	Ramos, A.
dc.authorsophos	Ruano, Y.
dc.authorsophos	Manneh, R.
dc.authorsophos	Perez Segura, P.
dc.authorsophos	Benavides, M.
dc.authorsophos	Balana, C.
dc.identifier.isi	361887402508
dc.identifier.sophos	18271
dc.issue.number	2902
dc.journal.title	EUROPEAN JOURNAL OF CANCER
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initial	S585
dc.page.final	S585
dc.rights.accessRights	openAccess
dc.typesophos	Artículo de Opinión
dc.volume.number	51

Files in this item

Files	Size	Format	View
There are no files associated with this item.